SCOPUS 정보 검색 플랫폼

Tumori

Volumn 86, Issue 5 SUPPL. 2, 2000, Pages

Cancer vaccines

(3) Carrabba, M a Parmiani, G a Rivoltini, L a

a NATIONAL CANCER INSTITUTE (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ANTIGEN RECOGNITION; CANCER IMMUNOLOGY; COLORECTAL CARCINOMA; CONFERENCE PAPER; FOLLICULAR LYMPHOMA; HUMAN; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PROSTATE CANCER; T LYMPHOCYTE;

ANIMALS; CANCER VACCINES; CLINICAL TRIALS; HUMANS; NEOPLASMS; TREATMENT OUTCOME;

EID: 0034488313 PISSN: 03008916 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (2)

References (14)

1
- 0032828653
- Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
- (1999) Nat. Med. , vol.5 , pp. 1171-1177
- Bendandi, M.¹ Gocke, C.D.² Kobrin, C.B.³ Benko, F.A.⁴ Sternas, L.A.⁵ Pennington, R.⁶ Watson, T.M.⁷ Reynolds, C.W.⁸ Gause, B.L.⁹ Duffey, P.L.¹⁰ Jaffe, E.S.¹¹ Creekmore, S.P.¹² Longo, D.L.¹³ Kwak, L.W.¹⁴

2
- 0031172777
- Tumor antigens recognized by T cells
- (1997) Immunol. Today , vol.18 , pp. 267-268
- Boon, T.¹ Coulie, P.G.² Van den Eynde, B.³

3
- 0033957167
- T-cell recognition of melanoma-associated antigens
- (2000) Cell Physiol. , vol.182 , pp. 323-331
- Castelli, C.¹ Rivoltini, L.² Andreola, G.³ Carrabba, M.⁴ Renkvist, N.⁵ Parmiani, G.⁶

4
- 0033579934
- Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
- (1999) Int. J. Cancer , vol.80 , pp. 219-230
- Marchand, M.¹ Van Baren, N.² Weynants, P.³ Brichard, V.⁴ Dreno, B.⁵ Tessier, M.H.⁶ Rankin, E.⁷ Parmiani, G.⁸ Arienti, F.⁹ Humblet, Y.¹⁰ Bourlond, A.¹¹ Vanwijck, R.¹² Lienard, D.¹³ Beauduin, M.¹⁴ Dietrich, P.Y.¹⁵ Russo, V.¹⁶ Kerger, J.¹⁷ Masucci, G.¹⁸ Jager, E.¹⁹ De Greve, J.²⁰ more..

5
- 0031941423
- Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
- (1998) Nat. Med. , vol.4 , pp. 328-332
- Nestle, F.O.¹ Alijagic, S.² Gilliet, M.³ Sun, Y.⁴ Grabbe, S.⁵ Dummer, R.⁶ Burg, G.⁷ Schadendorf, D.⁸

6
- 0031661691
- Future perspectives in specific immunotherapy of melanoma
- (1998) Eur. J. Cancer , vol.34 , Issue.SUPPL. 3
- Parmiani, G.¹

7
- 0034631328
- Immunological gene therapy with ex vivo gene-modified tumor cells: A critique and a reappraisal
- (2000) Hum. Gene Ther. , vol.11 , pp. 1269-1275
- Parmiani, G.¹ Rodolfo, M.² Melani, G.³

8
- 0028942142
- Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1
- (1995) J. Immunol. , vol.54 , pp. 2257-2265
- Rivoltini, L.¹ Kawakami, Y.² Sakaguchi, K.³ Southwood, S.⁴ Sette, A.⁵ Robbins, P.F.⁶ Marincola, F.M.⁷ Salgaller, M.L.⁸ Yannelli, J.R.⁹ Appella, E.¹⁰

9
- 0030713422
- Recognition of melanoma-derived antigens by CTL: Possible mechanisms involved in down-regulating anti-tumor T-cell reactivity
- (1998) Crit. Rev. Immunol. , vol.18 , pp. 55-63
- Rivoltini, L.¹ Loftus, D.J.² Squarcina, P.³ Castelli, C.⁴ Rini, F.⁵ Arienti, F.⁶ Belli, F.⁷ Marincola, F.M.⁸ Geisler, C.⁹ Borsatti, A.¹⁰ Appella, E.¹¹ Parmiani, G.¹²

10
- 0033847583
- Interleukin 2 and the development of immunotherapy for the treatment of patients with cancer
- (2000) Cancer Sci. Am. , vol.6
- Rosenberg, S.A.¹

11
- 0031890206
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- (1998) Nat. Med. , vol.4 , pp. 321-327
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Restifo, N.P.⁷ Dudley, M.E.⁸ Schwarz, S.L.⁹ Spiess, P.J.¹⁰ Wunderlich, J.R.¹¹ Parkhurst, M.R.¹² Kawakami, Y.¹³ Seipp, C.A.¹⁴ Einhorn, J.H.¹⁵ White, D.E.¹⁶

12
- 0033916359
- Conference on cancer vaccines
- (2000) Cancer Immunol. Immunother. , vol.49 , pp. 281-284
- Schadendorf, D.¹ Belardelli, F.² Ferrantini, M.³ Parmiani, G.⁴ Colombo, M.P.⁵

13
- 0033153295
- GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial
- (1999) Prostate , vol.39 , pp. 291-297
- Simmons, S.J.¹ Tjoa, B.A.² Rogers, M.³ Elgamal, A.⁴ Kenny, G.M.⁵ Ragde, H.⁶ Troychak, M.J.⁷ Boynton, A.L.⁸ Murphy, G.P.⁹

14
- 0033616482
- Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
- (1999) Lancet , vol.353 , pp. 345-350
- Vermorken, J.B.¹ Claessen, A.M.² Van Tinteren, H.³ Gall, H.E.⁴ Ezinga, R.⁵ Meijer, S.⁶ Scheper, R.J.⁷ Meijer, C.J.⁸ Bloemena, E.⁹ Ransom, J.H.¹⁰ Hanna M.G., Jr.¹¹ Pinedo, H.M.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.